95
Participants
Start Date
October 31, 2006
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Levodopa/carbidopa/entacapone
Patients were instructed to take the study medication at the same hours and the same levodopa dose they were taking prior to enrollment in this study. Levodopa/carbidopa/entacapone was available in 2 oral dosage forms: 100/25/200 or 150/37.5/200 mg encapsulated tablets.
Levodopa/carbidopa
Patients were instructed to take the study medication at the same hours and the same levodopa dose they were taking prior to enrollment in this study. Levodopa/carbidopa was available in 2 oral dosage forms: One or one and one-half 100/25 mg encapsulated tablets.
Hospital Juan Canalejo, A Coruña
Hospital Universitario Virgen de las Nieves, Granada
Policlínica Gipuzkoa, Donostia / San Sebastian
Clínica Ruber, Madrid
Hospital General Universitario Gregorio Marañon, Madrid
Fundación Jiménez Díaz, Madrid
Hospital Clínico San Carlos, Madrid
Hospital 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Principe de Asturias, Alcalá de Henares, Madrid
Fundación Hospital de Alcorcón, Alcorcón (Madrid
Universitaria de Navarra, Pamplona
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitario de la Fe, Valencia
Hospital Clínico Universitario de Valencia, Valencia
Hospital Gral. de Valencia, Valencia
Hospital General de Alicante, Alicante
Centro Médico Teknon, Barcelona
Hospital de la Santa Creu i de Sant Pau, Barcelona
Hospital Vall d'Hebron, Barcelona
Hospital Clínic i Provincial de Barcelona, Barcelona
Corporació Sanitària Parc Taulí Sabadell, Barcelona
Hospital General Yagüe, Burgos
Hospital Universitari Bellvitge Princeps d'Espanya, L'Hospitalet de Llobregat , Barcelona
Hospital General de Catalunya, Sant Cugat Del Valles, Barcelona
Hospital Mutua de Terrassa, Terrassa, Barcelona
Lead Sponsor
Novartis
INDUSTRY